rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

AH Equity Partners Bio II, L.L.C.

10% owner

Company insider

Files Form 4 as: 10% owner, Scribe Therapeutics; 10% owner, Nautilus Biotechnology; 10% owner, EQRx.

Every Form 4 they filed

In numbers

Trades disclosed
15
Buys
1
Sells
1
Bought
$5.0M
Sold
$11.8M
Companies
3
Companies where not an officer
3
First trade
9 Nov 2023
Last trade
27 Jul 2026
Last filed
29 Jul 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
SCTX Scribe Therapeutics10% owner · Biotechnology · last 27 Jul 20261 buy · 0 sells
NAUT Nautilus Biotechnology10% owner · Life-science tools · last 2 Jun 20260 buys · 1 sell
EQRx10% owner · last 9 Nov 20230 buys · 0 sells

Activity over time

1 Jun – 1 Oct
101Jun 26Jul 26Aug 26Sep 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
27 Jul 2026filed 29 Jul 2026SCTX Scribe Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code C—12,150,003 at $0.00filing
27 Jul 2026filed 29 Jul 2026SCTX Scribe Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code C—4,131,344 at $0.00filing
27 Jul 2026filed 29 Jul 2026SCTX Scribe TherapeuticsBiotechnologySEC FORM 4 Code C—2,051,742filing
27 Jul 2026filed 29 Jul 2026SCTX Scribe TherapeuticsBiotechnologySEC FORM 4 Code C—697,650filing
27 Jul 2026filed 29 Jul 2026SCTX Scribe TherapeuticsBiotechnologySEC FORM 4 Bought$5.0M333,333 at $15.00filing
2 Jun 2026filed 4 Jun 2026NAUT Nautilus BiotechnologyLife-science toolsSEC FORM 4 Sold$10.8M4,615,974 at $2.35filing
2 Jun 2026filed 4 Jun 2026NAUT Nautilus BiotechnologyLife-science toolsSEC FORM 4 Sold$902K384,026 at $2.35filing
9 Nov 2023filed 9 Nov 2023EQRxoption or derivativeSEC FORM 4 Code U—2,401,418filing
9 Nov 2023filed 9 Nov 2023EQRxoption or derivativeSEC FORM 4 Code U—2,642,897filing
9 Nov 2023filed 9 Nov 2023EQRxoption or derivativeSEC FORM 4 Code U—1,574,510filing
9 Nov 2023filed 9 Nov 2023EQRxSEC FORM 4 Code U—12,264filing
9 Nov 2023filed 9 Nov 2023EQRxSEC FORM 4 Code U—17,438,465filing
9 Nov 2023filed 9 Nov 2023EQRxSEC FORM 4 Code U—19,192,015filing
9 Nov 2023filed 9 Nov 2023EQRxSEC FORM 4 Code U—11,433,677filing
9 Nov 2023filed 9 Nov 2023EQRxSEC FORM 4 Code U—5,000,000filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Health Care2

Buys in green, sells in red, by the company’s sector.

Related people

AH Bio Fund II, L.P.10% owner · 10% owner at Scribe Therapeutics, filing Form 4 there in the last year
ORBIMED ADVISORS LLCDirector and 10% owner · Director at Scribe Therapeutics, filing Form 4 there in the last year
Carl L. GordonDirector and 10% owner · Director at Scribe Therapeutics, filing Form 4 there in the last year
Jennifer A. DoudnaDirector · 10% owner at Scribe Therapeutics, filing Form 4 there in the last year
Brett Staahl10% owner · 10% owner at Scribe Therapeutics, filing Form 4 there in the last year
Behzad AghazadehDirector and 10% owner and Other role · Also traded SCTX in the last 90 days